Caxton Associates (New York)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $524K | Sell |
5,671
-11,929
| -68% | -$1.1M | 0.02% | 318 |
|
|
2024
Q3 | $1.48M | Buy |
+17,600
| New | +$1.48M | 0.06% | 176 |
|
|
2024
Q2 | – | Sell |
-12,141
| Closed | -$889K | – | 522 |
|
|
2024
Q1 | $889K | Hold |
12,141
| – | – | 0.05% | 242 |
|
|
2023
Q4 | $984K | Hold |
12,141
| – | – | 0.05% | 229 |
|
|
2023
Q3 | $910K | Buy |
12,141
+3,436
| +39% | +$257K | 0.13% | 167 |
|
|
2023
Q2 | $671K | Buy |
+8,705
| New | +$671K | 0.1% | 213 |
|
|
2023
Q1 | – | Sell |
-769,230
| Closed | -$66M | – | 540 |
|
|
2022
Q4 | $66M | Buy |
+769,230
| New | +$66M | 4.41% | 5 |
|
|
2020
Q3 | – | Sell |
-6,247
| Closed | -$481K | – | 382 |
|
|
2020
Q2 | $481K | Buy |
+6,247
| New | +$481K | 0.04% | 133 |
|
|
2019
Q2 | – | Sell |
-3,219
| Closed | -$209K | – | 436 |
|
|
2019
Q1 | $209K | Buy |
+3,219
| New | +$209K | 0.03% | 320 |
|
|
2018
Q2 | – | Sell |
-13,202
| Closed | -$995K | – | 369 |
|
|
2018
Q1 | $995K | Buy |
+13,202
| New | +$995K | 0.05% | 144 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 187 |
|
|
2014
Q2 | – | Sell |
-50,000
| Closed | -$3.54M | – | 181 |
|
|
2014
Q1 | $3.54M | Buy |
+50,000
| New | +$3.54M | 0.22% | 61 |
|
|
2013
Q4 | – | Sell |
-250,000
| Closed | -$15.7M | – | 216 |
|
|
2013
Q3 | $15.7M | Buy |
250,000
+125,000
| +100% | +$7.86M | 0.82% | 20 |
|
|
2013
Q2 | $6.41M | Buy |
+125,000
| New | +$6.41M | 0.32% | 56 |
|